CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, May 10, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home2020

Yearly Archives: 2020

Lilly and Incyte Highlight Positive Data for Olumiant® in Rheumatoid Arthritis

admin - 0
November 02, 2020: "Eli Lilly and Company and Incyte announced positive data for Olumiant® (baricitinib) will be presented at ACR Convergence 2020, the American College of Rheumatology's virtual annual...

Oxford BioDynamics announces strategic partnership with Boca Biolistics

admin - 0
November 02, 2020: "Oxford BioDynamics Plc, a biotechnology company developing personalized medicine tests based on 3D genomics, has entered into a strategic partnership with...

EMA Validates Marketing Application for Filgotinib for Ulcerative Colitis

admin - 0
November 02, 2020: "Gilead Sciences, Inc. and Galapagos NV announced that the application for a new indication to the approved license for filgotinib 200...

AZ’S Atacand to be divested to Cheplapharm in more than 70 countries

admin - 0
30 October 2020: AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in around...

Novel COVID-19 Antibody Therapy Candidates Identified by Leading UK Biotech Consortium

admin - 0
29 October 2020: " The UK BIA Antibody Taskforce, a leading UK consortium developing antibodies for treating COVID-19 has reached a major milestone - the identification...

Novartis sickle cell medicine Adakveo® to prevent recurrent vaso-occlusive crises

admin - 0
October 30, 2020: "Novartis announced that the European Commission (EC) has approved Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in...

Enhertu granted Priority Review in the US for HER2 gastric cancer

admin - 0
October 28, 2020: "AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has received acceptance for its supplemental Biologics License Application (sBLA) and has...

Sanofi and GSK to support COVAX with 200 million doses of COVID-19 vaccine

admin - 0
 October 28, 2020: "Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing...

Oxford Sciences Innovation announces the sale of Base Genomics to Exact Sciences

admin - 0
October 27, 2020: "Base Genomics, an Oxford Sciences Innovation (OSI) portfolio company, has been acquired by Exact Sciences for a total consideration of $410m. Base...

AZ’s Tagrisso scores priority review from FDA with EGFR-mutated lung cancer

admin - 0
October 20, 2020: "AstraZeneca’s Tagrisso (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in the US...

Forxiga recommended for approval in the EU by CHMP for heart failure

admin - 0
October 19, 2020: "AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the treatment of...

AstraZeneca advances leadership in renal disease at ASN Kidney Week 2020 Reimagined

admin - 0
October 20, 2020: AstraZeneca will present 84 abstracts, including 12 oral presentations and three late-breaking abstracts, across its industry-leading renal portfolio which includes roxadustat, Farxiga (dapagliflozin)...
1...789...65Page 8 of 65
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved